UNSPSC 51191547: Ethiazide

This classification denotes a thiazide diuretic with the molecular formula C9H12ClN3O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EK9LSW731R, chemically known as 6-chloro-3-ethyl-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as ethiazide, which bears US NIH Compound Identifier 15763. European Medicines Agency schedules Ethiazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07275MIG. The term ETHIAZIDE is an International Non-Proprietary Name.

UNSPSC 51191547 Ethiazide is a Commodity code that in recent state and local procurement activity covers generic multi-source pharmaceuticals and over-the-counter products supplied through cooperative purchasing agreements, as well as chemical commodities for municipal water and wastewater treatment operations. State and local governments soliciting under this code include municipal utilities (water pollution control facilities), state departments of administration, and multistate cooperative purchasing alliances that aggregate demand across participating state and local government facilities. The scope of work spans both pharmaceutical supply arrangements with specified National Drug Codes and dosage forms, and industrial chemical supply for water treatment operations, with pricing typically evaluated on a unit-cost or competitive-pricing basis and contracts structured around firm pricing, administrative fees, and performance metrics.

Recent activity shows geographic spread across multiple states and regions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP for generic multi-source pharmaceuticals and OTC products on January 20, 2026, with a response due date of March 26, 2026; the resulting contracts will become effective July 1, 2026 and span participating state and local government facilities including Oregon. The City of Meriden, Connecticut issued an IFB for sodium bisulfite chemical supply for its Water Pollution Control Facility under solicitation B027-15, posted July 8, 2026 with bids due July 29, 2026. Vendors responding to pharmaceutical procurement under this code must maintain compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, secure contractual relationships with authorized wholesalers, and carry comprehensive insurance including commercial general liability of $5,000,000 per occurrence. Chemical suppliers must provide performance and labor and material payment bonds and maintain General Liability coverage of $1,000,000 to $2,000,000 as required by local authorities.